Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001415889-18-000763
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-17 16:08:31
Reporting Period:
2018-05-08
Accepted Time:
2018-05-17 16:08:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816284 Celgene Corp CELG Pharmaceutical Preparations (2834) 222711928
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1538897 J Mark Alles 86 Morris Avenue
Summit NJ 07901
Ceo, Chairman Of Board No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-09 1,208 $82.60 187,316 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2018-05-08 59,234 $0.00 59,234 $83.13
Common Stock Restricted Stock Unit Acquisiton 2018-05-08 30,079 $0.00 30,079 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
59,234 2028-05-08 No 4 A Direct
30,079 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,056 Indirect 401(k) Plan
Footnotes
  1. Option is immediately exercisable and will vest in four equal installments, commencing on May 8, 2019.
  2. The option was issued pursuant to the Company's 2017 Stock Incentive Plan.
  3. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
  4. The restricted stock units will fully vest on May 8, 2021. Vested shares will be delivered to the reporting person promptly after the vesting date.
  5. The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan.